Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

Relief Therapeutics Holding SA (RLFTF)

Compare
3.0600
-0.0400
(-1.29%)
At close: April 17 at 4:00:00 PM EDT
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
8,417
8,417
6,033
6,081
3,321
Cost of Revenue
2,575
2,575
1,736
1,250
19,774
Gross Profit
5,842
5,842
4,297
4,831
-16,453
Operating Expense
13,748
13,748
24,075
40,305
18,158
Operating Income
-7,906
-7,906
-19,778
-35,474
-34,611
Net Non Operating Interest Income Expense
-79
-79
-791
-1,902
-1,276
Other Income Expense
-11,371
-11,371
-91,115
-16,940
362
Pretax Income
-19,356
-19,356
-111,684
-54,316
-35,525
Tax Provision
-2,237
-2,237
-13,503
-3,526
-820
Net Income Common Stockholders
-17,119
-17,119
-98,181
-50,790
-34,705
Diluted NI Available to Com Stockholders
-17,119
-17,119
-98,181
-50,790
-34,705
Basic EPS
-3.62
-1.36
-8.35
-4.80
-4.00
Diluted EPS
-3.62
-1.36
-8.35
-4.80
-4.00
Basic Average Shares
12,481.6840
12,540.4390
11,752.4660
10,570.2810
8,982.6730
Diluted Average Shares
12,481.6840
12,540.4390
11,752.4660
10,570.2810
8,982.6730
Total Operating Income as Reported
-18,885
-18,885
-110,828
-52,040
-34,306
Total Expenses
16,323
16,323
25,811
41,555
37,932
Net Income from Continuing & Discontinued Operation
-17,119
-17,119
-98,181
-50,790
-34,705
Normalized Income
-6,867.5881
-6,867.5881
-18,025.8713
-34,630.8206
-35,040.0828
Interest Income
188
188
93
18
40
Interest Expense
215
215
330
1,434
797
Net Interest Income
-79
-79
-791
-1,902
-1,276
EBIT
-19,141
-19,141
-111,354
-52,882
-34,728
EBITDA
-16,580
-16,580
-108,036
-49,022
-32,692
Reconciled Cost of Revenue
2,575
2,575
1,736
1,250
19,774
Reconciled Depreciation
2,561
2,561
3,318
3,860
2,036
Net Income from Continuing Operation Net Minority Interest
-17,119
-17,119
-98,181
-50,790
-34,705
Total Unusual Items Excluding Goodwill
-11,591
-11,591
-91,179
-17,281
343
Total Unusual Items
-11,591
-11,591
-91,179
-17,281
343
Normalized EBITDA
-4,989
-4,989
-16,857
-31,741
-33,035
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0001
0
Tax Effect of Unusual Items
-1,339.5881
-1,339.5881
-11,023.8713
-1,121.8206
7.9172
12/31/2021 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NRXP NRx Pharmaceuticals, Inc.
1.9300
0.00%
 
CYDY CytoDyn Inc.
0.2000
-1.96%
 
CVAC CureVac N.V.
3.1200
-2.50%
 
NRXPW NRx Pharmaceuticals, Inc.
0.0605
+21.00%
 
TSOI Therapeutic Solutions International, Inc.
0.0003
+50.00%
 
IMU.AX Imugene Limited
0.0240
-7.69%
 
22UA.DE BioNTech SE
85.55
-1.67%
 
IDIA.SW Idorsia Ltd
1.1400
+1.42%
 
GLSI Greenwich LifeSciences, Inc.
8.95
+1.24%
 
BLRX BioLineRx Ltd.
2.8800
+3.97%